Posts for ALNYLAM PHARMACEUTICALS, INC. ($ALNY)

Discover Alnylam Pharmaceuticals' FY 2024 financial performance, highlighting revenue growth, strategic collaborations, and key risks. A must-read for investors considering their options.

Alnylam Pharmaceuticals, Inc. files an 8-K detailing significant corporate changes on February 13, 2025. Essential information for investors and stakeholders.

Explore Alnylam Pharmaceuticals' 8-K filing from January 12, 2025, revealing critical updates impacting investors. Stay informed with key financial insights and corporate changes.